Dr. Tenen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Beth Israel Medical Center
330 Brookline Ave
Boston, MA 02215Phone+1 617-667-5561
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1982 - 1984- Brigham and Women's HospitalResidency, Internal Medicine, 1978 - 1981
- Brigham and Women's HospitalResidency, Internal Medicine, 1975 - 1977
Harvard Medical SchoolClass of 1975
Certifications & Licensure
CA State Medical License 1977 - Present
MA State Medical License 1976 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Bone marrow niches orchestrate stem-cell hierarchy and immune tolerance.Kazuhiro Furuhashi, Miwako Kakiuchi, Ryosuke Ueda, Hiroko Oda, Simone Ummarino
Nature. 2025-02-01 - Super-silencer perturbation by EZH2 and REST inhibition leads to large loss of chromatin interactions and reduction in cancer growth.Ying Zhang, Kaijing Chen, Seng Chuan Tang, Yichao Cai, Akiko Nambu
Nature Structural & Molecular Biology. 2025-01-01 - Decreased PU.1 expression in mature B cells induces lymphomagenesis.Shinya Endo, Nao Nishimura, Kosuke Toyoda, Yoshihiro Komohara, Joaquim Carreras
Cancer Science. 2024-12-01
Press Mentions
Mutant p53 Drives Clonal Hematopoiesis Through Modulating Epigenetic PathwayDecember 11th, 2019
Grant Support
- Molecular Biology Of Myeloid DifferentiationNational Heart, Lung, And Blood Institute2012
- Oncogenesis And Myeloid Transcription Factors In AMLNational Cancer Institute2008–2012
- Hematopoietic Stem Cell CommitmentNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
- Targeting Leukemic Stem CellsNational Cancer Institute2008–2011
- Distinct Acute Myeloid Leukemia Subclasses With Cebpa MutationsNational Cancer Institute2007–2011
- Role Of C/Ebpalpha And MyelopoiesisNational Heart, Lung, And Blood Institute2001–2010
- Molecular Biology Of Human Myeloid DifferentiationNational Cancer Institute1986–2010
- FOXA2 And C/EBP Transcription Factors In The Pathogenesis And Treatment Of Lung CNational Cancer Institute2008–2009
- Molecular Biology Of Myeloid DifferentiationNational Cancer Institute2004–2008
- Interacting Factors In Hematopoiesis And LeukemiaNational Cancer Institute2003–2007
- Regulation Of The Human CD34 Stem Cell GeneNational Institute Of Diabetes And Digestive And Kidney Diseases1994–2007
- Transcription Factor Mutations And Human AMLNational Cancer Institute2000–2004
- Shared Resource For Transgenic Mouse Models Of CancerNational Cancer Institute1999–2003
- Oncogenesis And Myeloid Transcription In AMLNational Cancer Institute2002
- AAV Gene Therapy Of Stem Cells And MacrophagesNational Heart, Lung, And Blood Institute1999–2001
- Role Of ETS Factor PU.1 And C/Ebp-Alpha In MyelopoiesisNational Cancer Institute1997–2001
- ETS Protein Interactions In Hematopoiesis And LeukemiaNational Cancer Institute1997–2001
- C/EBP Alpha And MyelopoiesisNational Heart, Lung, And Blood Institute1996–2000
- New Vectors For Gene Expression In Hematopoietic CellsNational Heart, Lung, And Blood Institute1996–1999
- New Vectors For Gene Expression In Hematopoietic CellsNational Heart, Lung, And Blood Institute1996–1997
- Development Of Anti-Hiv Vectors In Monocytes/MacrophagesNational Institute Of Allergy And Infectious Diseases1990–1992
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
